Herbal hope: huaier granules target kidney side effect of lung cancer drugs

NCT ID NCT07358520

First seen Jan 25, 2026 · Last updated Jun 13, 2026 · Updated 18 times

Summary

This study tests whether Huaier Granules, a traditional Chinese medicine, can treat proteinuria (excess protein in urine) caused by two common lung cancer drugs, Bevacizumab and Anlotinib. About 40 adult lung cancer patients with mild to moderate proteinuria will take the granules for 16 weeks. The goal is to see if the treatment can reduce or stabilize protein levels, helping patients stay on their cancer therapy longer.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROTEINURIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-••••

Locations

  • Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

    Shanghai, Shanghai Municipality, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Xuzhou Central Hospital

    Xuzhou, Jiangsu, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.